Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ticagrelor generic release date?Can natural supplements match lipitor's cholesterol lowering power?How does jaypirca treat btk inhibitor resistant lymphoma?Does cymbalta cause sweating?When is it safe to combine aspirin and vascepa?
See the DrugPatentWatch profile for enbrel
What conditions can Enbrel treat? Enbrel is a medication used to treat several conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and certain types of juvenile idiopathic arthritis [1]. It works by reducing inflammation in the body and is often prescribed in combination with other medications. How does Enbrel work? Enbrel is an immunosuppressive medication that targets tumor necrosis factor-alpha (TNF-alpha), a protein that contributes to inflammation in the body. By blocking TNF-alpha, Enbrel reduces inflammation and slows down disease progression in affected joints and skin [2]. Effectiveness of Enbrel Numerous studies have demonstrated the effectiveness of Enbrel in managing symptoms and delaying progression of various autoimmune diseases. For example, a study published in the New England Journal of Medicine found that Enbrel significantly improved physical function and reduced joint damage in patients with rheumatoid arthritis [3]. Common side effects of Enbrel As with any medication, Enbrel can cause side effects, including an increased risk of infections, such as pneumonia and tuberculosis. Common side effects also include headaches, fatigue, and injection site reactions [4]. It's essential to discuss potential side effects with a healthcare provider before starting treatment. Patient concerns and considerations While Enbrel can be an effective treatment, patients should be aware of potential long-term risks, such as an increased risk of skin cancer and serious infections. Regular monitoring and follow-up with a healthcare provider are crucial to minimize these risks. Patent information and biosimilar availability Enbrel is a complex biological medication with several patents protecting its formulation and manufacturing process. According to DrugPatentWatch.com, the patent for Enbrel expires in 2029, which may lead to the entry of biosimilars into the market [5]. References: 1. [1] http://www.drugs.com/enbrel.html 2. [2] https://www.webmd.com/arthritis/rheumatoid-arthritis/what-is-enbrel 3. [3] https://www.nejm.org/doi/full/10.1056/NEJMoa022145 4. [4] https://www.crohns.colitisfoundation.org/diet-and-treatment-treatment-drugs/biologics/enbrel 5. [5] http://www.drugpatentwatch.com/drugs/enbrel/
Other Questions About Enbrel :